198 related articles for article (PubMed ID: 36304471)
1. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
Front Immunol; 2022; 13():990143. PubMed ID: 36304471
[TBL] [Abstract][Full Text] [Related]
2. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
[TBL] [Abstract][Full Text] [Related]
3. Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis.
Madera S; Chervo MF; Chiauzzi VA; Pereyra MG; Venturutti L; Izzo F; Roldán Deamicis A; Guzman P; Dupont A; Roa JC; Cenciarini ME; Barchuk S; Figurelli S; Lopez Della Vecchia D; Levit C; Lebersztein G; Anfuso F; Castiglioni T; Cortese E; Ares S; Deza EG; Gercovich FG; Proietti CJ; Schillaci R; Cordo Russo RI; Elizalde PV
Horm Cancer; 2020 Oct; 11(5-6):218-239. PubMed ID: 32632815
[TBL] [Abstract][Full Text] [Related]
4. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.
Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):725-34. PubMed ID: 24521998
[TBL] [Abstract][Full Text] [Related]
7. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis.
Schettini F; Martínez-Sáez O; Falato C; De Santo I; Conte B; Garcia-Fructuoso I; Gomez-Bravo R; Seguí E; Chic N; Brasó-Maristany F; Paré L; Vidal M; Adamo B; Muñoz M; Pascual T; Ciruelos E; Perou CM; Carey LA; Prat A
ESMO Open; 2023 Jun; 8(3):101214. PubMed ID: 37075698
[TBL] [Abstract][Full Text] [Related]
9. Mutational landscape of HSP family on human breast cancer.
Fernandez-Muñoz JM; Guerrero-Gimenez ME; Ciocca LA; Germanó MJ; Zoppino FCM
Sci Rep; 2024 May; 14(1):12471. PubMed ID: 38816397
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
[TBL] [Abstract][Full Text] [Related]
12. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
13. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.
Prat A; Carey LA; Adamo B; Vidal M; Tabernero J; Cortés J; Parker JS; Perou CM; Baselga J
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25139534
[TBL] [Abstract][Full Text] [Related]
14. Gene co-expression network approach for predicting prognostic microRNA biomarkers in different subtypes of breast cancer.
Adhami M; MotieGhader H; Haghdoost AA; Afshar RM; Sadeghi B
Genomics; 2020 Jan; 112(1):135-143. PubMed ID: 30735795
[TBL] [Abstract][Full Text] [Related]
15. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
16. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H
Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024
[TBL] [Abstract][Full Text] [Related]
18. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.
Su X; Malouf GG; Chen Y; Zhang J; Yao H; Valero V; Weinstein JN; Spano JP; Meric-Bernstam F; Khayat D; Esteva FJ
Oncotarget; 2014 Oct; 5(20):9864-76. PubMed ID: 25296969
[TBL] [Abstract][Full Text] [Related]
20. Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer.
Cheng Z; Guo Y; Sun J; Zheng L
Sci Rep; 2022 Aug; 12(1):14261. PubMed ID: 35995822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
